RECRUITINGOBSERVATIONAL
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
Disease Progression and Clinical Outcomes in Chronic Hepatitis B (CHB) Patients With Comorbid Nonalcoholic Fatty Liver Disease (NAFLD)
About This Trial
The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).
Who May Be Eligible (Plain English)
Who May Qualify:
- Liver biopsy proved CHB and/or NAFLD at baseline;
- Chinese
- Follow-up duration\>12 months
Who Should NOT Join This Trial:
- Other liver diseases;
- Secondary causes of hepatic steatosis;
- Alcohol abuse;
- Liver cirrhosis, cirrhosis related complications or HCC at baseline;
- Malignancy;
- History of liver transplantation
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Liver biopsy proved CHB and/or NAFLD at baseline;
* Chinese
* Follow-up duration\>12 months
Exclusion Criteria:
* Other liver diseases;
* Secondary causes of hepatic steatosis;
* Alcohol abuse;
* Liver cirrhosis, cirrhosis related complications or HCC at baseline;
* Malignancy;
* History of liver transplantation
Locations (1)
Humanity and Health GI and Liver Centre
Hong Kong, Hong Kong, China